Aerrane(Isoflurane), sold under the trade name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia.

The global Aerrane market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Aerrane volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Aerrane market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Aerrane Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Below 100ml
100-250ml
Above 250ml

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Baxter
AbbVie
Halocarbon
Piramal Critical Care
Aesica Queenborough
Abbott Laboratories
Toronto Research Chemicals
Abcam
VetOne
MedKoo Biosciences
JD Medical
Lunan Pharmaceutical